STK11 and metabolic dysfunction-associated steatotic liver disease: In line with the negative correlation between Sirt1 and Scd1, Sharma et al. [76] showed that treatment with Barbamine, a compound that activated the SIRT1/LKB1/AMPK pathway prevented the elevation in the expression of FAS and SCD1 in the liver of rats with MASLD induced by HFD.